Immunohistochemical assessment of tumor vascularity in recurrent Clark II melanomas using antibody to type IV collagen.
Thin melanomas, measuring 0.76 mm or less, are generally associated with an excellent prognosis. However, a certain subset of these seemingly innocuous lesions have been reported to develop recurrences. Therefore, the predictive values of currently accepted prognostic indicators have been questioned in thin melanomas. Several studies concerning tumor vascularity in melanoma and certain non-melanocytic malignancies suggest that the degree of vascularization correlates with growth rate and biologic aggressiveness. In the present study, we determined the vascularity of a small group of Clark level II melanomas that resulted in recurrence, and compared these results to an equal number of nonrecurrent lesions with similar prognostic indicators. Blood vessels were labeled by immunoperoxidase staining techniques for Type IV collagen, and quantified by image analysis. No statistical difference was found between the two groups when mean blood vessel counts and percent vascular area were measured. The recurrent tumors had a mean PVA of 4.68 compared to 4.34 for the nonrecurrent group (p = 0.677). The mean blood vessel count beneath the recurrent group was 29.6 per 400 x field, and the corresponding value for the nonrecurrent group was 31.8 (p = 0.681). Our data is preliminary within this limited group of tumors, yet it suggests that tumor vascularity is not a distinctive prognostic indicator by which eventual outcome can be predicted in thin Clark level II malignant melanomas.
Guffey
J M
JM
Cutaneous Oncology Program, Moffitt Cancer Center, University of South Florida, Tampa 33612, USA.
Chaney
J V
JV
Stevens
G L
GL
Schroer
K R
KR
Fenske
N A
NA
Reintgen
D
D
Glass
L F
LF
D000328:Adult; D000911:Antibodies, Monoclonal; D003094:Collagen / Q000276:immunology*; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000098:blood supply / Q000276:immunology / Q000473:pathology*; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000098:blood supply / Q000276:immunology / Q000473:pathology*; D009389:Neovascularization, Pathologic / Q000473:pathology*; D011446:Prospective Studies; D012878:Skin Neoplasms / Q000098:blood supply / Q000276:immunology / Q000473:pathology*
D000911:Antibodies, Monoclonal; D003094:Collagen